Literature DB >> 28514997

The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: HealthNuts age 4-year follow-up.

Rachel L Peters1, Jennifer J Koplin2, Lyle C Gurrin3, Shyamali C Dharmage3, Melissa Wake4, Anne-Louise Ponsonby2, Mimi L K Tang5, Adrian J Lowe3, Melanie Matheson3, Terence Dwyer6, Katrina J Allen7.   

Abstract

BACKGROUND: The HealthNuts study previously reported interim prevalence data showing the highest prevalence of challenge-confirmed food allergy in infants internationally. However, population-derived prevalence data on challenge-confirmed food allergy and other allergic diseases in preschool-aged children remain sparse.
OBJECTIVE: This study aimed to report the updated prevalence of food allergy at age 1 year from the whole cohort, and to report the prevalence of food allergy, asthma, eczema, and allergic rhinitis at age 4 years.
METHODS: HealthNuts is a population-based cohort study with baseline recruitment of 5276 one-year-old children who underwent skin prick test (SPT) to 4 food allergens and those with detectable SPT results had formal food challenges. At age 4 years, parents completed a questionnaire (81.3% completed) and those who previously attended the HealthNuts clinic at age 1 year or reported symptoms of a new food allergy were invited for an assessment that included SPT and oral food challenges. Data on asthma, eczema, and allergic rhinitis were captured by validated International Study of Asthma and Allergies in Childhood questionnaires.
RESULTS: The prevalence of challenge-confirmed food allergy at age 1 and 4 years was 11.0% and 3.8%, respectively. At age 4 years, peanut allergy prevalence was 1.9% (95% CI, 1.6% to 2.3%), egg allergy was 1.2% (95% CI, 0.9% to 1.6%), and sesame allergy was 0.4% (95% CI, 0.3% to 0.6%). Late-onset peanut allergy at age 4 years was rare (0.2%). The prevalence of current asthma was 10.8% (95% CI, 9.7% to 12.1%), current eczema was 16.0% (95% CI, 14.7% to 17.4%), and current allergic rhinitis was 8.3% (95% CI, 7.2% to 9.4%). Forty percent to 50% of this population-based cohort experienced symptoms of an allergic disease in the first 4 years of their life.
CONCLUSIONS: Although the prevalence of food allergy decreased between age 1 year and age 4 years in this population-based cohort, the prevalence of any allergic disease among 4-year-old children in Melbourne, Australia, is remarkably high.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergy; HealthNuts; allergic rhinitis; asthma; eczema; egg allergy; food allergy; longitudinal study; peanut allergy; population-based study; prevalence; sesame allergy

Mesh:

Substances:

Year:  2017        PMID: 28514997     DOI: 10.1016/j.jaci.2017.02.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  61 in total

1.  Comparison of sublingual immunotherapy and oral immunotherapy in peanut allergy.

Authors:  Wenming Zhang; Sayantani B Sindher; Vanitha Sampath; Kari Nadeau
Journal:  Allergo J Int       Date:  2018-06-06

Review 2.  Mechanisms that define transient versus persistent food allergy.

Authors:  M Cecilia Berin
Journal:  J Allergy Clin Immunol       Date:  2019-02       Impact factor: 10.793

Review 3.  Recent developments in understanding the mechanisms of food allergy.

Authors:  Zoe C Schmiechen; Katherine A Weissler; Pamela A Frischmeyer-Guerrerio
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

4.  Clinical factors associated with peanut allergy in a high-risk infant cohort.

Authors:  Scott H Sicherer; Robert A Wood; Tamara T Perry; Stacie M Jones; Donald Y M Leung; Alice K Henning; Peter Dawson; A Wesley Burks; Robert Lindblad; Hugh A Sampson
Journal:  Allergy       Date:  2019-07-15       Impact factor: 13.146

5.  Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy.

Authors:  Sharon Chinthrajah; Shu Cao; Cherie Liu; Shu-Chen Lyu; Sayantani B Sindher; Andrew Long; Vanitha Sampath; Daniel Petroni; Marco Londei; Kari C Nadeau
Journal:  JCI Insight       Date:  2019-11-14

6.  Sublingual immunotherapy for food allergy and its future directions.

Authors:  Stephen A Schworer; Edwin H Kim
Journal:  Immunotherapy       Date:  2020-07-02       Impact factor: 4.196

Review 7.  Epidemiology and Burden of Food Allergy.

Authors:  Christopher M Warren; Jialing Jiang; Ruchi S Gupta
Journal:  Curr Allergy Asthma Rep       Date:  2020-02-14       Impact factor: 4.806

Review 8.  Microfluidic methods for precision diagnostics in food allergy.

Authors:  Nicolas Castaño; Seth C Cordts; Kari C Nadeau; Mindy Tsai; Stephen J Galli; Sindy K Y Tang
Journal:  Biomicrofluidics       Date:  2020-04-03       Impact factor: 2.800

9.  Ovomucoid epitope-specific repertoire of IgE, IgG4 , IgG1 , IgA1 , and IgD antibodies in egg-allergic children.

Authors:  Maria Suprun; Robert Getts; Galina Grishina; Angela Tsuang; Mayte Suárez-Fariñas; Hugh A Sampson
Journal:  Allergy       Date:  2020-06-01       Impact factor: 13.146

10.  Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy.

Authors:  Edwin H Kim; Tamara T Perry; Robert A Wood; Donald Y M Leung; M Cecilia Berin; A Wesley Burks; Christine B Cho; Stacie M Jones; Amy Scurlock; Scott H Sicherer; Alice K Henning; Peter Dawson; Robert W Lindblad; Marshall Plaut; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2020-06-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.